| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062737A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062731A1 Pyridine-amidines as modulators of p38 map kinase |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062717A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | WO2001062715A1 Novel cd23 inhibitors |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062713A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062704A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062341A2 Combination product for the treatment of obesity |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062263A2 Use of pentosan polysulfate for the manufacture of a medicament for the treatment of male chronic pelvic pain syndrome |
| 08/30/2001 | WO2001062252A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062239A2 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | WO2001062238A2 Ppar gamma agonists for the treatment of liver inflammatory disorders |
| 08/30/2001 | WO2001062223A2 Cosmetic preparations containing plant extracts |
| 08/30/2001 | WO2001027098A3 Method for producing cox-2 inhibitors |
| 08/30/2001 | WO2001016335A3 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 08/30/2001 | WO2001012606A3 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/30/2001 | WO2001010457A3 Pharmaceutical compositions containing tripeptides |
| 08/30/2001 | WO2001009350A3 Genetically engineered bleb vaccine |
| 08/30/2001 | WO2001002540A3 Adenoviral vectors for treating disease |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018443 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 08/30/2001 | US20010018068 Water insoluble substrate comprising creped nonwoven layer and cleansing component (lathering surfactant); cleaning/ conditioning skin/hair; disposable; materials handling |
| 08/30/2001 | DE10008329A1 New aminosulfonyl-biphenyl derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or angina pectoris |
| 08/30/2001 | CA2683009A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2401226A1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | CA2401190A1 Pyridine-amidines as modulators of p38 map kinase |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400948A1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins |
| 08/30/2001 | CA2400923A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400896A1 Novel compositions and uses of dictyostatin compounds |
| 08/30/2001 | CA2400875A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400797A1 Therapeutic agents |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399298A1 Use of il-18 inhibitors |
| 08/30/2001 | CA2399211A1 Foam-forming wound dressing |
| 08/30/2001 | CA2399018A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397234A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | CA2396960A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | EP1127883A2 Oxamides as IMPDH inhibitors |
| 08/29/2001 | EP1127878A1 3,4 - substituted pyrazoles for the treatment of inflammation |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127574A1 Use of chitinous materials for inhibiting cellular nitric oxide production |
| 08/29/2001 | EP1127572A2 Use of flavones for treating cycloxygenase-2 mediated diseases |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1127064A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127054A1 Novel inhibitors of impdh enzyme |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126845A2 New use of immunosuppressants for mmp-mediated diseases |
| 08/29/2001 | EP1126843A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126837A1 Fulvic acid and its use in the treatment of various conditions |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126830A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 08/29/2001 | EP1126829A1 Particles coated with granulated crystalline ibuprofen |
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP0876141B1 Preparations of non-steroidal analgesics |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | CN1310724A Novel peptides for use in immunotherapy of autoimmune diseases |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310706A Inhibitors of phospholipase enzymes |
| 08/29/2001 | CN1310621A Substituted anilide compounds and methods |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/29/2001 | CN1309990A Perfume incense oil composition easy to be absorbed by body and its preparation and use |
| 08/29/2001 | CN1309986A Chinese medicine health tea for dispelling wind-evil and wetness-evil |
| 08/29/2001 | CN1309977A Medicine for treating thrombus and rheumatism |
| 08/29/2001 | CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same |
| 08/29/2001 | CN1070061C Antioncotic antalgesic Zanthoxylum nitidum tablet |
| 08/29/2001 | CN1070057C Antipyretic sponge bath agent composition for external use and its preparation and application |